Navigation Links
Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
Date:8/21/2007

Enterprise-Wide Solutions Designed to Increase Efficiency

MINNEAPOLIS, Aug. 21 /PRNewswire-FirstCall/ -- Vital Images, Inc. (Nasdaq: VTAL), a leading provider of enterprise-wide advanced visualization and analysis solutions, today announced it has released its next generation enterprise-wide advanced visualization and analysis product solutions with the release of Vitrea(R) 4.0 and ViTALConnect(R) 4.1. This comprehensive package offers powerful advanced visualization and analysis capabilities via workstation clients, remote clients and Web-based clients. These releases include significant enhancements to the company's powerful cardiovascular, neurovascular and gastrointestinal applications as well as improved Web-based cardiovascular analysis and distribution capabilities. In addition to the new version enhancements, the company also released ViTAL EP, a new electrophysiology (EP) planning application to augment its world class cardiovascular suite of products and Medicsight's ColonCAD(TM) for its InnerviewGI(TM) virtual colonoscopy application.

"Vital Images' Vitrea workstation-client set the productivity standard for advanced visualization and analysis clinical solutions," said Jay D. Miller, president and chief executive officer for Vital Images. "We've taken that same 'complexity made simple' approach to provide the most powerful tools via our Web-client, giving customers the ability to access these tools from anywhere at any time."

Enhancements to the company's Vitrea 4.0 workstation-client release include cardiovascular workflow enhancements such as automatic segmentation and probing of the coronary tree, easier vessel management and labeling, easy centerline editing and comprehensive rep
'/>"/>

SOURCE Vital Images, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related biology technology :

1. Report Reveals Vitality of SE Wisconsin Technology Community
2. Counting Colonies or Plaques Directly from Images of Agar Plates
3. Madisons PunchStock acquired by Getty Images
4. TeraMEDICA offers seamless sharing of digital medical images
5. Images from new telescope to be released Thursday
6. Two Milwaukee finance IT firms agree to exchange check images
7. Merge eMed releases software upgrade
8. Sony releases tool for Blu-ray disc production
9. NameProtect releases annual list of top trademarkers
10. Small Tree releases fiber-optic gigabit Ethernet adapters for Mac OS X
11. Paragon releases MidMarkIT Suite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , Oct. 20, 2014 Asterias Biotherapeutics, ... Company has signed a Notice of Grant Award ... (CIRM), effective October 1, 2014.  The NGA provides ... and the release of additional grant funds pursuant ... award for clinical development of Asterias, product, AST-OPC1. ...
(Date:10/20/2014)... Inc. (NASDAQ: GNVC ) today announced the retirement ... of directors effective on October 24, 2014.   Dr. Horovitz joined ... chairman from June 2006 to November 2013.  During his tenure, ... Audit Committees of the board.  "We deeply ... to GenVec, and its stockholders," said Wayne T. Hockmeyer ...
(Date:10/20/2014)... Earle Martin , Chief ... that Ellen Teplitzky, an experienced attorney specializing in ... industry, has joined the firm as Director of ... practice. NDA Partners provides legal services, including ... to top law firms and their clients in ...
(Date:10/19/2014)... OCTOBER 20-22, 2014: The ... ABIM will take place at the Congress ... 2014 is now available at http://www.abim.ch ... and organizations from all over the globe ... the latest products and developments on the ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2
... Reportlinker.com announces that a new market research ... Global Anticoagulants Industry ... worldwide markets for Anticoagulants in US$ Million by ... Anticoagulants (Unfractionated Heparin, & Low Molecular Weight Heparin). ...
... Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
... GENEVA and RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2010 ... therapeutics, today presented an update to the World Health ... antiviral compound, CMX001, at the 12th Meeting of the ... presentation titled "Status of CMX001 for Smallpox and Other ...
Cached Biology Technology:Reportlinker Adds Global Anticoagulants Industry 2Reportlinker Adds Global Anticoagulants Industry 3Reportlinker Adds Global Anticoagulants Industry 4Reportlinker Adds Global Anticoagulants Industry 5Reportlinker Adds Global Anticoagulants Industry 6Reportlinker Adds Global Anticoagulants Industry 7Reportlinker Adds Global Anticoagulants Industry 8Reportlinker Adds Global Anticoagulants Industry 9Reportlinker Adds Global Anticoagulants Industry 10Reportlinker Adds Global Anticoagulants Industry 11Reportlinker Adds Global Anticoagulants Industry 12Reportlinker Adds Global Anticoagulants Industry 13Reportlinker Adds Global Anticoagulants Industry 14Reportlinker Adds Global Anticoagulants Industry 15Reportlinker Adds Global Anticoagulants Industry 16Reportlinker Adds Global Anticoagulants Industry 17Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 2Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 3Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 4Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 5Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 6Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 7Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 8Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 9Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session 10Chimerix Presents Update on CMX001 Development to the World Health Organization Advisory Committee on Variola Virus Research 2Chimerix Presents Update on CMX001 Development to the World Health Organization Advisory Committee on Variola Virus Research 3
(Date:10/18/2014)... sample of patients with undiagnosed, suspected genetic conditions, a ... a higher molecular diagnostic yield than traditional molecular diagnostic ... . The study is being released to coincide with ... Exome sequencing, which sequences the protein­coding region of the ... present in a cell or organism), has been rapidly ...
(Date:10/17/2014)... German . ... in order to reproduce? And why are there two sexes ... latest issue of the research journal Molecular Human Reproduction ... Ramm from Bielefeld University Bielefeld has compiled this special issue ... a female to copulate with several males in quick succession ...
(Date:10/17/2014)... German . ... When treating overdoses, doctors are often limited to supportive therapy ... is a combination of drugs involved. So what can be ... grandmother,s pills? ETH professor Jean-Christophe Leroux from the Institute of ... to this question. "The task was to develop an agent ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
... Alexandria, VA Age-related hearing loss (ARHL), one of the ... with low serum levels of folic acid, according to new ... Head and Neck Surgery . Hearing loss ... 28 million Americans between the ages of 60 and 74 ...
... that incorporates the surrounding landscape in unprecedented detail describes ... and seed dispersal in cotton plants more accurately than ... at the University of Arizona,s College of Agriculture and ... in PLoS ONE on Nov. 30. ...
... A new study published in the Journal of the ... by Autism Speaks, found that children with autism have more ... dysfunctional mitochondria. These new findings from UC Davis reveal ... way of screening for these deficits using blood samples. ...
Cached Biology News:Gene transfer from transgenic crops: A more realistic picture 2Gene transfer from transgenic crops: A more realistic picture 3Children with autism more likely to have mitochondrial defects impacting cellular energy production 2
Request Info...
IgD Chain C (AMS 9.1)...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Applications: Epitope mapping, Mapping protein-protein contacts, Identification of enzyme substrates/inhibitors, Identification of receptor agonists/antagonists...
Biology Products: